Composition for ameliorating peripheral sensory neuropathy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11793845
APP PUB NO 20210275616A1
SERIAL NO

17328401

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

No drug has been available for treating a peripheral sensory neuropathy caused as a side effect by a drug, in particular, by an anticancer drug such as oxaliplatin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KINKI UNIVERSITY3-4-1 KOWAKAE HIGASHIOSAKA-SHI OSAKA 5778502
KOBAYASHI PHARMACEUTICAL CO LTD4-10 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 5410045 ?5410045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nishida, Shozo Osaka, JP 14 108
Okuno, Kiyotaka Osaka, JP 2 1
Takeda, Tomoya Osaka, JP 31 156
Tsubaki, Masanobu Osaka, JP 5 1
Wachi, Satoshi Osaka, JP 45 292

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 24, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00